Published on in Vol 24, No 6 (2022): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33446, first published .
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Rawa Kamaran Ismail 1*, PhD, PharmD;  Jesper van Breeschoten 2*, PharmD;  Silvia van der Flier 3, PhD;  Caspar van Loosen 4, MSc;  Anna Maria Gerdina Pasmooij 5, PhD;  Maaike van Dartel 5, PhD;  Alfons van den Eertwegh 6, PhD, MD;  Anthonius de Boer 1, MD, PhD;  Michel Wouters 7, MD, PhD;  Doranne Hilarius 8, PhD, PharmD

1 Division of Pharmacoepidemiology and Clinical Pharmacology, University of Utrecht , Utrecht , NL

2 Dutch Institute for Clinical Auditing , Leiden , NL

3 Stichting Volksgezondheidszorg (VGZ) , Arnhem , NL

4 Dutch Association of Hospital Pharmacists , De Meern , NL

5 Medicines Evaluation Board , Utrecht , NL

6 Department of Medical Oncology, Amsterdam University Medical Center, location VUmc , Amsterdam , NL

7 Department of Biomedical Data Sciences, Leiden University Medical Centre , Leiden , NL

8 Rode Kruis Ziekenhuis , Beverwijk , NL

*these authors contributed equally

Corresponding Author: